Skip to main content
RARE logo
RARE
(NASDAQ)
Ultragenyx Pharmaceutical Inc.
$25.83-- (--)
Loading... - Market loading

Ultragenyx Pharmaceutical (RARE) Stock Price & Financial Analysis

Ultragenyx Pharmaceutical Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$25.69 - $26.75
52-Week High$39.89
52-Week Low$18.29
Open$25.76
Volume2.39M
Average Volume (3M)1.93M
Market Cap2.60B
Shares Outstanding100.60M
Price to Sales (P/S)3.93
Price to Book (P/B)-11.14
EV/EBITDA-7.26
Revenue (TTM)669.43M
Net Income (TTM)-609.36M
Free Cash Flow (TTM)-505.85M
EPS (TTM)$-6.11
Profit Margin-91.03%
Operating Margin-83.92%
50-Day MA$28.06
200-Day MA$26.60
52-Week Change-11.99%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ultragenyx Pharmaceutical

What is the current stock price for RARE?

As of the latest trading session, RARE stock trades at $25.83. The 52-week range is $18.29–$39.89, with a day range of $25.69–$26.75.

What is the P/E ratio for RARE?

The P/E ratio (Price-to-Earnings) for RARE is shown in the Key Statistics section. This valuation metric helps compare Ultragenyx Pharmaceutical Inc. to industry peers.

Does RARE pay dividends?

Ultragenyx Pharmaceutical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RARE?

Based on 3 analysts, the consensus for RARE is Buy.

What is the market cap of RARE?

Ultragenyx Pharmaceutical's market capitalization is $2.60B, classifying it as a mid-cap company. Ultragenyx Pharmaceutical operates in the Healthcare sector within the Biotechnology industry.